Published by Michele Maatouk on 12th December 2023
(Sharecast News) - Pfizer said on Tuesday that it has now received all regulatory approvals needed to close its $43bn acquisition of Seagen after agreeing to donate the rights of royalties from sales of its Bavencio cancer drug.
URL: http://www.digitallook.com/dl/news/story/33966628/...